Metformin pre-treatment retains an antioxidant effect and decreases apoptosis, in an AMPK activation manner. by Silvia Siteni (10344070)

“…(C, D) Furthermore, metformin significantly decreases the expression of cleaved PARP, compared to the irradiated control. …”

The anti-HCMV CRISPR/Cas9 system induces mutations resulting in a decrease in IE protein expression in primary fibroblasts. by Janina Gergen (4856863)

Significant decrease of SMAD4 protein in DBA iPSCs. by Jingping Ge (636557)

“…A) Slight decrease of mRNA level of <i>SMAD4</i> in the DBA iPSCs with <i>RPS19</i> or <i>RPL5</i> mutations. …”

Combination treatments increased p53 and decreased c-Myc levels in U-87MG and U-251MG cells more than did single treatments. by Panchanan Maiti (1459852)

“…<p>A-C: Western blot data showed that SLCP+BBR increased p53 and decreased c-Myc levels significantly more in U-87MG and U-251MG cells, in comparison to single treatments. …”

GluN2A(D731N) decreases current amplitudes and shortens synaptic-like response time course. by Kai Gao (120150)

Subjects:

Serotonin deficiency decreases calcium transporters expression in the mammary gland on d 10 of lactation. by Jimena Laporta (383836)

Inhibition of G9a decreases the tumorigenicity of neuroblastoma cells. by Xiao-Xue Ke (626989)

The Intracellular level of FLASH decreases during apoptosis. by Song Chen (69646)

Healthspan decreases in response to cell-associated factor LPS in a dose-dependent manner. by Gabriel M. Moore (8566113)

Downregulation of DOM decreases the abundance of PER and TIM. by Zhenxing Liu (399809)

“…Downregulation of DOM decreased PER levels at CT1-5 and CT17-21. (Scale bar: 50 um.) …”

Laquinimod prevents EAE and decreases encephalitogenicity of T cells. by Ulf Schulze-Topphoff (174453)

“…<p>DBA/1 (A) mice and C57BL/6 mice (B) were treated daily with laquinimod (25 mg/kg, n = 6/group) or vehicle (water, n = 6/group) starting from the day of immunization with rMOG 1-125 (DBA/1) or MOG p35-55 (C57BL/6). …”

Nicotinamide decreases BAL PMNs but causes significant hypoxemia in VILI. by Heather D. Jones (476855)

ACOT1 decreases ROS in rodent heart. by Shenglan Yang (112488)

STZ Decreases Akt Activity in Rat Striatum by Jason M Williams (61649)

A brief course of RAP treatment decreases markers of proliferation and increases markers of differentiation. by Karin M. Hardiman (555189)

“…<p><i>CDX2P-CreER^T2 Apc^fl/fl</i> mice were injected with TAM and monitored until polyposis was seen endoscopically, then the mice were treated with vehicle or RAP at 3 mg/kg concentration for periods of one, three, or five days (N = 5 per timepoint). …”

Administration of Tamoxifen decreases PD-induced peritoneal membrane thickness in a mouse model. by Jesús Loureiro (405934)

RUE decreases expression of inflammatory cytokines through MAPK-NF-κB pathway. by Jeong Hoon Pan (844624)

MK-STYX decreases RhoA activation. by Brittany M. Flowers (670483)

“…Anti-phospho-cofilin antibody showed that MK-STYX decreased cofilin phosphorylation in non-stimulated cells relative to the MK-STYX shRNA-A. …”

Preconditioning anti-VEGF antibody decreased IR-induced pulmonary edema and microvascular hyper-permeability. by Chou-Chin Lan (2938674)

“…<p><b>(A)</b> Lung weight (LW) and wet/dry weight (W/D) was significantly increased in the IR group (p<0.05) and decreased in the B5-IR (p<0.05). …”

Decrease of SMAD3 protein, but not SMAD2 in DBA iPSCs. by Jingping Ge (636557)

“…The nuclear p-SMAD2 decreased in <i>RPL5</i> mutant and corrected lines. …”